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Edited by Beat ImhofAbstract Therapeutic peptides and small molecules, rationally
designed to trigger cell death have attracted strong attention.
Cell death inducible peptides were screened from amino acid
sequence of tumor necrosis factor-related apoptosis-inducing
ligand (TRAIL). Using Fmoc solid phase synthesis, cellulose
membrane-bound octameric peptide library of TRAIL scan
was prepared and cell viability assay was directly performed
on peptide disk with Jurkat cells. Six peptide sequences that
could induce cell death were found. Peptide sequence with
RNSCWSKD (TRAIL227–234) that exist in the zinc-binding site
revealed high cell death inducible activity. Apoptotic cell death
was observed when cells were treated with soluble synthesized
peptide.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Peptide ligands that interact with cell surface receptors for
cell signaling can be excellent leads for antagonist develop-
ment. Screening of small peptides or small molecules that mod-
ulate protein–protein interaction continues to be major
challenge for drug discovery since these molecules enable to
provide targeted therapy. Numbers of therapeutic peptides
and small molecules have been designed to trigger cell death
and entering the clinic against cancer [1–4].
Tumor necrosis factor (TNF)-related apoptosis-inducing li-
gand (TRAIL), a member of the TNF family, is particularly
interesting for its unique ability to induce cancer cell death
while sparing most normal cells, which implies its use as a po-
tent anti-cancer agent [5]. TRAIL is a type II transmembrane
protein that exists as a homotrimeric jelly roll proteins [6].
TRAIL has been shown to interact with the cell surface
through ﬁve distinct receptors, death receptor (DR) 4, DR5,Abbreviations: Calcein AM, calcein acetoxymethyl ester; MAP, multi-
ple antigenic peptide; TNF, tumor necrosis factor; TRAIL, TNF-rel-
ated apoptosis-inducing ligand
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(TRAIL-R1) and DR5 (TRAIL-R2) possess an intracellular
tail containing a conserved motif known as the death domain
and allow interaction with the downstream adaptor proteins to
initiate apoptosis signals. In contrast, TRAIL-R3 (DcR1) and
TRAIL-R4 (DcR2) contain an incomplete non-functional
death domain and act as decoys, inhibit signaling through
TRAIL-R1 and -R2 [7]. Osteoprotegrin is a secreted decoy
receptor that binds to TRAIL with lower aﬃnity than other
receptors. Since TRAIL and its receptors are constitutively ex-
pressed in almost tissues and induction of apoptosis does not
depend on p53 statuses that are considered to be critical factor
in cancer therapies, TRAIL attracted considerable attention as
a potential therapeutic to human cancers.
From our previous experiments [8], cell death peptide has
been screened from human Fas antigen ligand sequence using
peptide array. A novel 5mer peptide, CNNLP (Cys-Asn-Asn-
Leu-Pro) that exist in the Fas ligand–receptor interaction site
revealed cell death eﬀect. Peptide array has been utilized to
identify active peptides and explore analogue peptides with im-
proved activity. The method for synthesizing large numbers of
peptides on cellulose membrane was developed by Frank [9]
using the Fmoc solid phase peptide synthesis. The SPOT tech-
nology enables to synthesize variety of peptides from the C to
the N-terminus in one membrane in a parallel manner and pro-
vides versatile tools for molecular recognition and screening of
biologically active peptides [10–13]. Screening of peptide li-
gands for cell surface receptors will extend peptide array appli-
cations from probing protein–protein interactions to imitating
cell signaling.
In the present study, high-throughput screening of cell death
inducible peptides was performed with peptide-scan of the
TRAIL extracellular domain that interacts with its receptor.
The direct cell assay of cell death inducible peptides was per-
formed using peptide array. Techniques that rapidly assess bio-
molecular interactions between receptors on the surfaces of
mammalian cells and synthetic ligands of extracellular matrix
proteins are critical in the ﬁelds of biomaterials, medicals,
and tissue engineering.2. Materials and methods
2.1. Preparation of peptide arrays covering the amino acid sequence of
TRAIL
Peptide library of 8mer peptides overlapping by 6 residues of
TRAIL sequence (position 39–281 that is annotated as extracellular
domain) was prepared by automated spot synthesis. The cellulose
membrane (Whatman, Maidstone, UK) was activated using b-alanineblished by Elsevier B.V. All rights reserved.
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duced as the spacer. Standard Fmoc-chemistry was used in accordance
with the manufacturer’s instructions (Intavis, Ko¨ln, Germany), with
some modiﬁcations. The activated amino acids were spotted using a
peptide auto-spotter (model ASP222, Intavis). Activated amino acids
at a concentration of 0.25 M were spotted at 80 mm intervals. The
membrane was washed with N,N 0-dimethyl formamide, and deprotec-
ted with 20% piperidine. Additional washes were performed with N,N 0-
dimethyl formamide, followed by washing with methanol. These steps
were repeated in this order at every elongation step. The removal of the
side-chain protecting group was carried out with 50% triﬂuoroacetic
acid, 3% tri-isopropylsilane, 2% water in dichloromethane for 3 h.
After removal of protecting group, membrane was washed several
times with diethyl ether and methanol, and was allowed to dry.
2.2. Cell assay with peptide array
The synthesized peptide array was washed for more than 12 h with
phosphate buﬀered saline, and then soaked in methanol for steriliza-
tion. After the array allowed drying under sterile condition, peptide
spots were punched out and settled in the 96-well plate. Jurkat cells
at cell concentration of 2.0 · 105 cells/ml were inoculated and cells were
incubated for 48 h on peptide bound membrane without injection of
serum. One hour before the time point of measurement, calcein acet-
oxymethyl ester (calcein AM, Molecular Probes Inc., Eugene, OR,
USA) that is an indicator for living cells was applied to a ﬁnal concen-
tration of 5 lM. Fluorescent intensity was measured by ﬂuorescence
plate reader (type 374, Fluoroskan Ascent, Labsystems, Helsinki, Fin-
land). For each peptide, triplet spots were synthesized on an array.
Relative ﬂuorescent intensity was calculated using the no-peptide
bound membrane as the control.
The eﬀectiveness of screened peptides was also examined with solu-
ble peptides. Synthesized linear peptide (purity above 80%) and multi-
ple antigenic peptide (MAP) were obtained from Operon
Biotechnologies Inc. (Tokyo, Japan). Tetra-branching MAP is a mul-
timerized peptide with carboxyl terminal linkages of poly-lysine and
used to higher peptide density interact with cell surface. Fluorescent
intensity of cells after incubation for 24 and 48 h was measured using
calcein AM.
2.3. Cell death analysis
Apoptotic cells were detected by DNA staining using Hoechst
33258. Jurkat cells (1.0 · 105 cells/ml) were incubated with 2 mM pep-
tide No. 95 and 0.1 mMMAP form of peptide No. 95 for 5 h. The cells
were collected and resuspended in 10 lM Hoechst 33258 dissolved in
phosphate buﬀered saline. Apoptotic cell stain was also performed
using annexin V-Alexa Fluor 488 binding to phosphatidylserine
expressed on the cell membrane in the early phase of apoptosis using
Vybrant Apoptosis kit #2 (Molecular Probes Inc.). The cells were col-
lected and resuspended in annexin-binding buﬀer containing calcium,
annexin V-Alexa Fluor 488, and propidium iodide. After 15-min incu-
bation, cells were observed using ﬂuorescent microscope (model IX71,
Olympus, Tokyo, Japan). TRAIL (100 ng/ml) was used as a control
apoptotic cells.
2.4. Compositional characterization of cell death inducible peptides
Characterization of cell death inducible peptides was performed with
ﬁve site that show decreased ﬂuorescent intensity with 13 peptide (Nos.
6–9, 18–20, 66, 81, and 93–96). The number of occurrences of each
amino acid in the sequence of TRAIL39–281 (extracellular) and in the
site that revealed cell death eﬀect was enumerated.Table 1
Sequence of screened 8mer peptide that induced cell death
Peptide number Peptide sequence Relative ﬂuorescent intensitya
7. KSGIACFL 0.39 ± 0.19
8. GIACFLKE 0.41 ± 0.17
20. CWQVKWQL 0.50 ± 0.20
81. NTKNDKQM 0.48 ± 0.26
94. SARNSCWS 0.45 ± 0.28
95. RNSCWSKD 0.21 ± 0.03
The average ﬂuorescent intensity of 106 peptides that did not revealed
cell death eﬀect (negative peptides) was 0.86 ± 0.22.
aMean value of two diﬀerent peptide array experiments containing
triplicate spots.3. Results
3.1. Screening of cell death inducible peptide using 8mer peptide
library of TRAIL peptide-scan
Octameric peptide library covering extracellular domain se-
quence of TRAIL was prepared with and without introducing
Fmoc-amino undecanoic acid as a spacer. Signiﬁcant decrease
in relative ﬂuorescent intensity of Jurkat cells stained with cal-
cein AM after 48-h incubation on peptide disk was not ob-
served without introducing the spacer. In contrast, relativeﬂuorescent intensity distinctly decreased at some peptides.
These results indicate that screening of cell death inducible
peptides can be performed by the direct cell assay using peptide
array when introducing the spacer that would increase the ﬂex-
ibility of short peptides bound to cellulose membrane.
Detailed cell assay was performed with 8mer peptide library
of TRAIL peptide-scan. The average ﬂuorescent intensity of
106 peptides that did not reveal cell death eﬀect (negative pep-
tides) was 0.86 ± 0.22. Table 1 shows the sequence of peptides
with relative ﬂuorescent intensity below 0.50. Five sites that
revealed low ﬂuorescent intensity were found; peptide number
6–9 at TRAIL49–62 (YSKSGIACFLKEDD), Nos. 18–20 at
TRAIL73–84 (MNSPCWQV KWQL), No. 66 at TRAIL169–175
(LRNGELVI), No. 81 at TRAIL198–206 (NTKNDKQM),
and Nos. 93–96 at TRAIL223–236 (MKSARNSCWSKDAE)
(Fig. 1). Among these peptides, relative ﬂuorescent intensity
of peptide Nos. 7, 8 and 95 were below 0.42 (mean value
± 2S.D.) and regarded as statistically low. Peptide No. 95
was 0.21 ± 0.03 and showed the strongest eﬀect. It was shown
that cell death inducible peptides were screened from the ami-
no acid sequence of TRAIL using peptide array.
3.2. Soluble peptide eﬀect on Jurkat cells
Fig. 2 shows the eﬀect of screened peptide No. 95 with sol-
uble form. When cells were incubated with soluble
RNSCWSKD peptide at 2 mM, cell growth was not observed.
With RERGPQRV peptide used as a negative control peptide
(No. 39) that revealed no eﬀect in Fig. 1, viable cell number in-
creased after 24- and 48-h incubation.
To further examine the eﬀect of peptide No. 95, cells were
incubated with MAP form with four anchoring peptides. With
0.5 mMMAP form of No. 95, the viable cell concentration de-
creased as with TRAIL (Fig. 3). The eﬀect was further high
compared to the 2.0 mM free peptide in Fig. 2. Cell growth
was not observed even at 0.01 mM MAP form of No. 95. It
was indicated that the MAP form will allow interaction of cells
at higher density and thus aﬀected cells eﬀectively. Therefore, it
was shown that the screened peptide No. 95 induced cell death
in the soluble form and worked eﬀectively in the MAP form.
3.3. Apoptosis analysis of Jurkat cells treated with linear and
MAP form of peptide No. 95
To evaluate whether the peptide No. 95 (RNSCWSKD) can
induce apoptosis, cells after 5-h incubation with linear and
MAP formof peptideNo. 95 andwithout peptidewere observed
by ﬂuorescent microscope after DNA staining with Hoechst
33258. As shown in Fig. 4, stereotypic morphological changes
in nucleus (chromatin condensation) were observed with the
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Fig. 1. Screening of cell death inducible peptides using 8mer peptide library of TRAIL-scan. Relative ﬂuorescent intensity of Jurkat cells after 48 h of
incubation on peptide disk was measured by staining with calcein AM. No peptide bound disk membrane was used as the control. Each point
represents the average value of triplicate spots on two diﬀerent peptide arrays. Broken lines indicate average relative ﬂuorescent intensity ± S.D.
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Fig. 2. Eﬀect of synthesized soluble peptide on Jurkat cells. Jurkat
cells (2 · 105 cells/ml) were inoculated with 2 mM peptide No. 95
(RNSCWSKD; d), peptide No. 39 (RERGPQRV; m), 3 nM TRAIL
(·), and without peptide addition (s).
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Fig. 3. Eﬀect of RNSCWSKD MAP. Jurkat cells (2 · 105 cells/ml)
were inoculated with MAP form (0.5 mM; d, 0.01 mM; e) or linear
form (j) of 0.5 mM RNSCWSKD. 3 nM TRAIL (·) and no peptide
(s) condition was used as a positive and negative control, respectively.
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TRAIL treated cells. The number of cells stained with Hoechst
33258 was higher when cells were treated with MAP form of
peptide. Also, phosphatidylserine externalization on the cells
membrane was observed using annexin V. Most of cell treated
with linear and MAP form of peptide No. 95 were stained with
annexinV. Some of the cells were double stainedwith propidium
iodide indicating these cells are in the later phase of apoptosis.
These observations indicated that the peptide No. 95 induced
apoptosis and its eﬀect was higher in the MAP form.
3.4. Compositional characterization of cell death inducible
peptides
Characterization of cell death inducible peptides was per-
formed with 13 peptide sequences that show decreased ﬂuores-
cent intensity (No. 6–9, 18–20, 66, 81, and 93–96). Fig. 5 shows
the number of occurrences of each amino acid in the sequenceof TRAIL39–281 (extracellular) and in ﬁve sites that revealed
cell death eﬀect (TRAIL49–62, TRAIL73–84, TRAIL169–175,
TRAIL198–206, TRAIL223–236). From the enumeration, it was
revealed that cell death inducible peptides were enriched in cys-
teine and tryptophan. All of three cysteine residue exists in the
TRAIL sequence were included in these sites revealed cell
death. Abundance of lysine and serine was high in these sites
and TRAIL39–281. Also, histidine was underrepresented (nil).
Therefore, cysteine was indicated to play as a key residue in
the 8mer cell death inducible peptides.4. Discussion
In assessing the biological activities of small molecules, it is
useful to consider not only protein binding but also phenotypic
eﬀects. Since peptides can be excellent leads for drug, peptide
Fig. 4. Fluorescent microscopic observation of Jurkat cells treated with linear (A, C) and MAP form (B, D) of peptide No. 95. (A, B) DNA staining
was performed with Hoechst 33258. (C, D) Phosphatidylserine externalization (annexin V-Alexa Fluor 488) and nuclear condensation of cells
decreased membrane permeability (propidium iodide).
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Fig. 5. Compositional characterization of cell death inducible peptides. The number of occurrences of each amino acid in the sequence of TRAIL39–281
(h) and in the active site (No. 6–9, 18–20, 66, 81, and 93–96; j) that revealed cell death eﬀect were enumerated.
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screening by their ability to assay both protein interaction
and phenotypic eﬀects. Recently, large numbers of peptides
synthesized by SPOT technology have been utilized to screen
peptide variants with improved antimicrobial activity [13]. A
high-throughput screening assay was performed with complete
substitution library of the 12mer peptide of bovine bactenecin
by cleaving peptides from cellulose support. In the present
study, we have investigated the screening of cell death induc-
ible peptides by the direct cell assay without cleaving peptides.Peptides bound at high density (usually approximately
300 nmol/cm2) on a cellulose support eﬀectively induced cell
death. The screened peptide could also aﬀect cells in a soluble
form and worked more eﬀectively in the MAP form since pep-
tide density interact to cell surface is higher (Fig. 3).
Recent studies indicated that protein–protein interactions oc-
cur through small binding epitopes and small peptides that
have high aﬃnities to such binding epitopes may be suﬃcient
for the regulation of large protein–protein interactions
[14,15]. Exocyclic peptidomimetics or synthetic peptides corre-
M. Okochi et al. / FEBS Letters 580 (2006) 885–889 889sponding to ligand-binding region of death receptors, DR5,
Fas, and TNFR were reported to function eﬀectively and inhi-
bit cell death [14,16,17]. The most eﬀective cell death inducible
peptide No. 95 (RNSCWSKD) that indicated apoptotic cell
death include C230 exist in the zinc binding site. The zinc ion
buried at the trimmer interface is required for maintaining
the native structure, stability and biological activity of TRAIL
[18–20]. In the site direct mutagenesis of C230A and C230S,
apoptotic activity highly decreased. Also, peptide No. 81
(NTKNDKQM) in the AA loop showed deceased ﬂuorescent
intensity. The major extension of AA loop is the unique site
of TRAIL within the TNF family and it is the site for interac-
tion with DR5 receptor. Also, with our previous study for
screening of cell death peptide from human Fas antigen ligand
sequence, a 5mer peptide CNNLP that contained P206 re-
ported to involve in the receptor–ligand interaction was found
to induce cell death [8]. Therefore, the TRAIL derived peptide
No. 95 indicated to induced apoptosis in this study might has
the ability to interact with its receptors and can partly substi-
tute for TRAIL function. Future study is necessary to investi-
gate the interaction of TRAIL derived active peptides with
DR4 and DR5 receptors and ﬁnd out the mechanism of induc-
ing apoptosis.
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